Tactile Systems Technology (TCMD) EBIT Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -20.56% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 11.83% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -11.06% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 19.54% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 20.97% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 74.18% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 90.95% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -18.12% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 46.60% |
| 10 | Tactile Systems Technology | 539.21 Mn | 449.02 Mn | 57.61 Mn | 66.23% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 66.23% |
| Dec 31, 2025 | 496.68% |
| Sep 30, 2025 | 61.67% |
| Jun 30, 2025 | -30.19% |
| Mar 31, 2025 | -53.24% |
| Dec 31, 2024 | -61.15% |
| Sep 30, 2024 | -15.12% |
| Jun 30, 2024 | 184.21% |
| Mar 31, 2024 | 22.12% |
| Dec 31, 2023 | -137.41% |
| Sep 30, 2023 | 593.15% |
| Jun 30, 2023 | 150.35% |
| Mar 31, 2023 | 74.46% |
| Dec 31, 2022 | 108.50% |
| Sep 30, 2022 | -18.51% |
| Jun 30, 2022 | -5,277.63% |
| Mar 31, 2022 | -264.86% |
| Dec 31, 2021 | -46.15% |
| Sep 30, 2021 | -176.20% |
| Jun 30, 2021 | 99.05% |
| Mar 31, 2021 | 8.25% |
| Dec 31, 2020 | 15.57% |
| Sep 30, 2020 | -43.99% |
| Jun 30, 2020 | -361.25% |
| Mar 31, 2020 | -147.00% |
| Dec 31, 2019 | 183.19% |
| Sep 30, 2019 | 133.80% |
| Jun 30, 2019 | 132.49% |
| Mar 31, 2019 | 1.37% |
| Dec 31, 2018 | -56.65% |
| Sep 30, 2018 | 8.90% |
| Jun 30, 2018 | 79.59% |
| Mar 31, 2018 | 37.69% |
| Dec 31, 2017 | 49.67% |
| Sep 30, 2017 | 29.16% |
| Jun 30, 2017 | -59.26% |
| Mar 31, 2017 | -64.17% |
| Dec 31, 2016 | 1.45% |
| Sep 30, 2016 | -33.38% |
| Jun 30, 2016 | 685.96% |